NAFLD patients showed dramatic differences in the metabolic fate of acetyl-CoA and elevated rates of pyruvate carboxylase flux, gluconeogenesis, EGP, and oxygen consumption37–39. This evidence concerns the gene PC and metabolic dysfunction-associated steatotic liver disease.